Diabetic rats given MOTS-c had lower blood sugar levels after fasting, showing better control of glucose.

Obese mice given MOTS-c injections for three days had lower blood sugar levels than mice that didn't receive the treatment.

After a week of MOTS-c injections, mice could process insulin better, needing 30% more glucose to keep blood sugar stable during a test.

MOTS-c treatment made the diabetic rats' heart cells have more mitochondria, which are the energy factories of cells.

People with type 2 diabetes have less MOTS-c in their blood than people without diabetes.

When diabetic rats were given MOTS-c daily for three weeks, their heart walls became slightly thinner, which is a sign of less heart enlargement.